UMass Memorial Medical Center has taken a comprehensive approach to limit clinician-industry interaction. Restrictions on the ability to designate education funds for specific clinical topics will pose a challenge to grantees seeking pharmaceutical dollars, though. The vendor relations policy was adopted by the heath system in December and will be voted on by its board this month. But the policy could deal a blow to industry-supported education. Companies must submit grants to the hospital's foundation first and cannot earmark educational dollars to particular physicians or to a particular program within the department.
Pages to are hidden for
"Will pharma grants run dry at UMass?"Please download to view full document